Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score

Aim: Growing evidence indicated that CYP2C19 genotypes could only explain a fraction of the pharmacodynamic response to clopidogrel, while a number of clinical factors also have contributing roles. Our objective was to develop a new risk score to improve prognostication of ischemic events in Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hongyi, Li, Xiaoye, Qian, Juying, Zhao, Xin, Yao, Yao, Lv, Qianzhou, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977638/
https://www.ncbi.nlm.nih.gov/pubmed/35387342
http://dx.doi.org/10.3389/fphar.2022.854867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977638/
https://www.ncbi.nlm.nih.gov/pubmed/35387342
http://dx.doi.org/10.3389/fphar.2022.854867

Ejemplares similares